KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Raw Materials (2016 - 2019)

Pfizer has reported Raw Materials over the past 11 years, most recently at $560.0 million for Q1 2019.

  • Quarterly Raw Materials fell 32.12% to $560.0 million in Q1 2019 from the year-ago period, while the trailing twelve-month figure was $560.0 million through Mar 2019, down 32.12% year-over-year, with the annual reading at $546.0 million for FY2018, 30.71% down from the prior year.
  • Raw Materials was $560.0 million for Q1 2019 at Pfizer, up from $546.0 million in the prior quarter.
  • Over five years, Raw Materials peaked at $950.0 million in Q3 2016 and troughed at $475.0 million in Q1 2015.
  • The 5-year median for Raw Materials is $809.0 million (2016), against an average of $754.1 million.
  • Year-over-year, Raw Materials surged 84.82% in 2016 and then crashed 32.12% in 2019.
  • A 5-year view of Raw Materials shows it stood at $867.0 million in 2015, then decreased by 8.54% to $793.0 million in 2016, then decreased by 0.63% to $788.0 million in 2017, then tumbled by 30.71% to $546.0 million in 2018, then increased by 2.56% to $560.0 million in 2019.
  • Per Business Quant, the three most recent readings for PFE's Raw Materials are $560.0 million (Q1 2019), $546.0 million (Q4 2018), and $839.0 million (Q3 2018).